CMS Announces Billing Change for COVID-19 Vaccine & Monoclonal Antibody Products for MA Plan Beneficiaries

By: Kathie McDonald-McClure

Centers for Medicare & Medicaid Services (CMS) changed the Medicare payment policy for COVID-19 vaccines and monoclonal antibody products effective January 1, 2022. According to the CMS MLN Connects News for January 6, 2022, providers who administer COVID-19 vaccinations or monoclonal antibody treatments to patients enrolled in Medicare Advantage (MA) plans (as opposed to Original Medicare) are to submit claims to the MA Plan. This change applies to COVID-19 vaccinations and monoclonal antibody treatments administrated on or after January 1, 2022.  CMS states that Original Medicare will not pay these claims.

For additional information regarding COVID-19 vaccination billing, visit the CMS webpage Medicare Billing for COVID-19 Vaccine Shot Administration.

For additional information regarding monoclonal antibody treatment billing, visit the CMS webpage Monoclonal COVID-19 Infusion.

Kathie McDonald-McClure
Kathie McDonald-McClure leads the Firm’s Data Privacy & Cyber Security practice and is a member of the Health Care Service Team. Her longtime passion for and attention to technology-related matters has given her a leg-up in assisting clients with regard to data privacy and cyber security. She regularly advises businesses and business managers on compliance with HIPAA, FERPA, GLBA, GDPR, and state data privacy and breach reporting laws. Because data privacy has become so interconnected with... Read More